Melinda Sanders

15PUBLICATIONS
144CO-AUTHORS
Haematological tumoursCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 19, 2025
Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner.

Sarah C Reed, Chad R Potts, Leo Y Luo

|Aug 20, 2025
Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis.

Jeremy Williams, Roman Camarda, Serghei Malkov

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|Jan 13, 2025
In Situ Detection of Individual Classic MHC-I Gene Products in Cancer.

Paula I Gonzalez-Ericsson, Susan R Opalenik, Violeta Sanchez

|Jul 15, 2024
Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort.

Xiaopeng Sun, Laura C Kennedy, Paula I Gonzalez-Ericsson

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

Pageof 3